(Q38810990)

6 September 2017

Alternatively spliced isoforms of IL-32 differentially influence cell death pathways in cancer cell lines (English)

1 reference

6 September 2017

1 reference

6

Charles A Dinarello

1 reference

6 September 2017

5

Mihai G Netea

1 reference

6 September 2017

9

Leo A B Joosten

1 reference

6 September 2017

Bas Heinhuis

1

1 reference

6 September 2017

Theo S Plantinga

2

1 reference

6 September 2017

George Semango

3

1 reference

6 September 2017

Benno Küsters

4

1 reference

6 September 2017

Jan W A Smit

7

1 reference

6 September 2017

Romana T Netea-Maier

8

1 reference

6 September 2017

language of work or name

English

0 references

publication date

17 December 2015

1 reference

6 September 2017

9

1 reference

based on heuristic

inferred from page(s)

published in

Carcinogenesis

1 reference

6 September 2017

37

1 reference

6 September 2017

2

1 reference

6 September 2017

197-205

1 reference

IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.

6 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

IL-32, a proinflammatory cytokine in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Interleukin-32: a cytokine and inducer of TNFalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Involvement of IL-32 in activation-induced cell death in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Towards a role of interleukin-32 in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

IL-32 expression is an independent prognostic marker for gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Interleukin-32β stimulates migration of MDA-MB-231 and MCF-7cells via the VEGF-STAT3 signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Expression of IL-32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Interleukin-32 expression in the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Overexpression of IL-32alpha increases natural killer cell-mediated killing through up-regulation of Fas and UL16-binding protein 2 (ULBP2) expression in human chronic myeloid leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

The role of IL-32 in cutaneous T-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Antitumor activity of IL-32β through the activation of lymphocytes, and the inactivation of NF-κB and STAT3 signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Interleukin-32 enhances cytotoxic effect of natural killer cells to cancer cells via activation of death receptor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Therapeutic effectiveness of intratumorally delivered dendritic cells engineered to express the pro-inflammatory cytokine, interleukin (IL)-32.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

The biflavonoid amentoflavone induces apoptosis via suppressing E7 expression, cell cycle arrest at sub-G₁ phase, and mitochondria-emanated intrinsic pathways in human cervical cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Interleukin 32 promotes hematopoietic progenitor expansion and attenuates bone marrow cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Molecular characterization of IL-32 in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

IL-32 promotes angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

The interleukin-8 pathway in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

IL-8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL-8 receptor type A or type B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Interleukin-32: a predominantly intracellular proinflammatory mediator that controls cell activation and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Interleukin 32 (IL-32) contains a typical α-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

A novel splicing variant of mouse interleukin (IL)-24 antagonizes IL-24-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

IL-32 and Streptococcus pyogenes cell wall fragments synergise for IL-1-dependent destructive arthritis via upregulation of TLR-2 and NOD2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV172

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGV172

1 reference

6 September 2017

1 reference